Año: 2020
Journal Impact Factor (JIF): 5.1910
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| PHARMACOLOGY & PHARMACY | SCIE | 57/276 | Q1 | T1 | D3 |
| MICROBIOLOGY | SCIE | 39/136 | Q2 | T1 | D3 |
Año: 2020
Journal Citation Indicator (JCI): 1,400
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| MICROBIOLOGY | 18/151 | Q1 | T1 | D2 | 88,41 |
| PHARMACOLOGY & PHARMACY | 31/357 | Q1 | T1 | D1 | 91,46 |
Año:
2020
CiteScore:
9,100
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Infectious Diseases | 24/288 | Q1 | T1 | D1 |
| Pharmacology | 28/297 | Q1 | T1 | D1 |
| Pharmacology (medical) | 15/246 | Q1 | T1 | D1 |
SJR año:
2020
Factor de Impacto:
2,070
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Infectious Diseases | 28/335 | Q1 | T1 | D1 |
| Pharmacology | 19/331 | Q1 | T1 | D1 |
| Pharmacology (medical) | 12/285 | Q1 | T1 | D1 |
| Agencia | Código de Proyecto |
|---|---|
| ESGBIES study group | - |
| ESGICH study group | - |
| European Development Regional Fund A Way To Achieve Europe, Operative Program Intelligent Growth 2014-2020 | - |
| Gilead | - |
| Instituto de Salud Carlos III, Subdireccion General de Redes y Centros de Investigacion Cooperativa, Ministerio de Economia, Industria y Competitividad, Spanish Network for Research in Infectious Diseases | REIPI RD16/0016/0001 |
| Pfizer | - |
| Promex Stiftung fur die Forschung (Carigest SA) | - |
| Spanish Plan Nacional de I+D+i 2013-2016 | - |
| # | Autor | Afiliación |
|---|---|---|
| 1 | Instituto de Salud Carlos III; Hospital Universitari de Bellvitge; Hospital Duran i Reynals (Spain) | |
| 2 | Albasanz-Puig, A. | Instituto de Salud Carlos III; Hospital Universitari de Bellvitge (Spain) |
| 3 | Laporte-Amargos, J. | Hospital Universitari de Bellvitge (Spain) |
| 4 | Pallarès, N. | Institut d'Investigació Biomedica de Bellvitge (Spain) |
| 5 | Mussetti, A. | Hospital Duran i Reynals (Spain) |
| 6 | Ruiz-Camps, I. | Instituto de Salud Carlos III; Hospital Universitari Vall d'Hebron (Spain) |
| 7 | Puerta-Alcalde, P. | Instituto de Salud Carlos III; Hospital Clinic Barcelona (Spain) |
| 8 | Abdala, E. | Universidade de Sao Paulo - USP (Brazil) |
| 9 | Oltolini, C. | IRCCS San Raffaele Scientific Institute (Italy) |
| 10 | Akova, M. | Hacettepe University, Faculty of Medicine (Turkey) |
| 11 | Montejo, M. | Instituto de Salud Carlos III; Osakidetza, Cruces University Hospital (Spain) |
| 12 | Mikulska, M. | Ospedale Policlinico San Martino (Italy) |
| 13 | Martín-Dávila, P. | Instituto de Salud Carlos III; Hospital Ramon y Cajal (Spain) |
| 14 | Herrera, F. | Centro de Educacion Medica e Investigaciones Clinicas Norberto Quirno (Argentina) |
| 15 | Gasch, O. | Instituto de Salud Carlos III; Hospital Parc Taulí (Spain) |
| 16 | Drgona, L. | Comenius University (Slovakia) |
| 17 | Paz Morales, H. | Hospital Erasto Gaertner (Brazil) |
| 18 | Brunel, A. S. | Centre Hospitalier Universitaire Vaudois (Switzerland) |
| 19 | García, E. | Hospital Universitario Reina Sofia (Spain) |
| 20 | Isler, B. | Istanbul Education and Research Hospital (Turkey) |
| 21 | Kern, W. V. | Universität Freiburg im Breisgau (Germany) |
| 22 | Morales, I. | Hospital Universitario Virgen Macarena; Instituto de Salud Carlos III (Spain) |
| 23 | Maestro-de la Calle, G. | Hospital Universitario 12 de Octubre (Spain) |
| 24 | Montero, M. | Universitat Autònoma de Barcelona; Instituto de Salud Carlos III (Spain) |
| 25 | Kanj, S. S. | American University of Beirut Medical Center (Lebanon) |
| 26 | Sipahi, O. R. | Ege Üniversitesi (Turkey) |
| 27 | Calik, S. | University of Health Sciences (Turkey) |
| 28 | Márquez-Gómez, I. | Hospital Regional Universitario Carlos Haya (Spain) |
| 29 | Marín, J. I. | Clínica Maraya; Critical Care and Clinical Microbiology Department (Colombia) |
| 30 | Gomes, M. Z. R. | Fundacao Oswaldo Cruz (Brazil) |
| 31 | Hemmatti, P. | Charité – Universitätsmedizin Berlin (Germany) |
| 32 | Araos, R. | Universidad del Desarrollo; Millennium Initiative for Collaborative Research on Bacterial Resistance (MICROB-R) (Chile) |
| 33 | Peghin, M. | Università degli Studi di Udine (Italy) |
| 34 | del Pozo, J. L. | Clinica Universitaria de Navarra (Spain) |
| 35 | Yáñez, L. | Hospital Universitario Marqués de Valdecilla (Spain) |
| 36 | Tilley, R. | Plymouth Hospitals NHS Trust (United Kingdom) |
| 37 | Manzur, A. | Hospital Rawson (Argentina) |
| 38 | Novo, A. | Hospital Universitario Son Espases (Spain) |
| 39 | Instituto de Salud Carlos III; Hospital Universitari de Bellvitge (Spain) | |
| # | Autoría grupal | Afiliación |
| 1 | Cueto López, Marina (IRONIC Study Group) | Sin datos () |
| 1 | Rodríguez-Baño, Jesús (IRONIC Study Group) | Sin datos () |
